Option Care Health (NASDAQ:OPCH) Releases Q4 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its fourth quarter 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.460-0.490 for the period, compared to the consensus estimate of 0.440. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Option Care Health also updated its FY 2025 guidance to 1.720-1.760 EPS.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on OPCH shares. TD Cowen decreased their price target on Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft upped their price target on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Morgan Stanley began coverage on shares of Option Care Health in a research note on Friday, October 17th. They set an “overweight” rating and a $35.00 target price for the company. JMP Securities set a $36.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Finally, Citizens Jmp decreased their price target on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $36.27.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.26 during trading on Monday, hitting $32.06. 1,516,765 shares of the company’s stock traded hands, compared to its average volume of 1,555,112. Option Care Health has a twelve month low of $24.24 and a twelve month high of $35.53. The company has a market cap of $5.09 billion, a PE ratio of 25.44, a PEG ratio of 1.98 and a beta of 0.80. The firm’s fifty day moving average price is $30.83 and its 200 day moving average price is $29.40. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of OPCH. Advisory Services Network LLC bought a new stake in Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC bought a new stake in Option Care Health in the second quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health in the third quarter worth $38,000. Quarry LP boosted its position in shares of Option Care Health by 502.7% during the third quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the period. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.